Antipsychotic therapy and short-term serious events in older adults with dementia

Archives of Internal Medicine

Volumn 168, Issue 10, 2008, Pages 1090-1096

  Rochon, Paula A ^a,b,c,d,l   Normand, Sharon Lise ^h,i   Gomes, Tara ^c   Gill, Sudeep S ^c,j   Anderson, Geoffrey M ^b,c   Melo, Magda ^c,g   Sykora, Kathy ^c   Lipscombe, Lorraine ^a,c,e   Bell, Chaim M ^a,b,c,f   Gurwitz, Jerry H ^k  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j QUEEN S UNIVERSITY   (Canada)

^k UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^l Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

AGED; ARTICLE; COMMUNITY; DEATH; DEMENTIA; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHORT COURSE THERAPY;

AGED; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 44349132828     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.10.1090     Document Type: Article

References (26)

1. Rapoport M. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry. 2005;20(8):749-753.
2. Lee PE, Sykora K, Gill SS, et al. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults. J Am Geriatr Soc. 2005;53(8):1374-1379.
3. Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med. 2005;165(16):1882-1888.
4. Hien LT, Cumming RG, Cameron ID, et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc. 2005;53:1290-1295.
5. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316(7):363-369.
6. Liperoti R, Gambassi G, Lapane K, et al. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry. 2005;66(9):1090-1096.
7. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ. 2005;330(7489):445.
8. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335-2341.
9. Gill S, Bronskill SE, Normond SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775-786.
10. Bronskill SE, Anderson CB, Sykora K, et al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact. J Am Geriatr Soc. 2004;52(5):749-755.
11. American Psychiatric Association. Practice guidelines for the treatment of patients with delirium. Am J Psychiatry. 1999;156(5) (suppl):1-20.
12. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry. 2007;68(1):11-21.
13. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351(9112):1303-1307.
14. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167(7):676-683.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
16. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non randomized control group. In: D'Agostino RB, ed. Tutorials in Biostatistics, Volume 1: Statistical Methods in Clinical Studies. New York, NY: John Wiley & Sons; 2004:67-84.
17. International Conference on Harmonization. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. http://www.ich.org/cache/compo/276-254-1.html. Accessed February 28, 2008.
18. Liperoti R, Onder G, Lapane KL, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiatry. 2007;68(6):929-934.
19. Health Canada, Canadian Adverse Drug Reaction Monitoring Program, Marketed Health Products Directorate. Important drug safety information: RISPERDAL(risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials - Janssen-Ortho. http://hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/ risperdal1_e.html. Accessed February 28, 2008.
20. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3):191-210.
21. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA. 2005;294(15):1934-1943.
22. Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med. 2005;118(3):251-258.
23. Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ. 2004;329(7457):75-78.
24. Rochon PA, Fortin PR, Dear KBG, Minaker KL, Chalmers TC. Reporting of age data in clinical trials of arthritis: deficiencies and solutions. Arch Intern Med. 1993;153(2):243-248.
25. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268(11):1417-1422.
26. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355(15):1525-1538.